Company: SCAG
Filing Date: 2025-01-06
Form Type: 424B3
Source: 0001213900-25-001215
Chunk: 389

Company: Scage Future
Filing Date: 2025-01-06
Form: 424B3
Chunk 389
---
 non -operatingitems, primarily including depreciation and amortization of US$0.5 million, amortization of right -of -useasset of US$0.2 million and inventory write -downof US$0.2 million; and (2) changes in working capital that negatively affected the cash flow from operating activities, primarily including: an increase in inventories of US$1.7 million, mainly due to the increased level of inventory stock for positive forecast of upcoming sales; a decrease in lease liabilities of US$0.2 million, due to increase of lease payments; partially offset by changes in working capital that positively affected the cash flow from operating activities, primarily including (1) an increase in accrued expenses and other current liabilities of US$1.7 million due to the increase in accrued employee payroll and welfare benefits as the result of business expansion; and (2) an increase in contract liabilities of US$1.2 million due to the increases in the contracts signed and advances received from customers. Investing activities Our net cash used in investing activities was US$1.6million for the fiscal year ended June30, 2024, primarily due to an increase of loans to third parties of US$1.8million. Our net cash used in investing activities was US$0.2 million for the fiscal year ended June 30, 2023, primarily due to an increase of purchase of property and equipment of US$0.2 million. Financing activities Our net cash provided by financing activities was US$8.7million for the fiscal year ended June30, 2024, primarily due to (1) proceeds from short -termbank loans of US$12.3million; (2) contribution from redeemable non -controllinginterests of US$2.8million; (3) proceeds from issuance of convertible redeemable preferred shares, net of issuance costs of US$0.9million; partially offset by (1) repayments of short -termbank loans of US$6.2million; (2) payments for listing expenses of US$0.6million and (3) repayment of loans to related parties of US$0.6million. Our net cash provided by financing activities was US$6.2 million for the fiscal year ended June 30, 2023, primarily due to (1) proceeds from short -termbank loans of US$2.4 million; (2) proceeds from issuance of preferred shares, net of issuance costs of